Biocon said the proceeds would be primarily used to meet the cash consideration payable to Mylan Inc, now Viatris, for the ...
If you are bothered about the uncertainties and volatility in the market, you can consider investing in aggressive hybrid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback